MYXEDEMA HEART. WILBUR E. FLANNERY, M.D. and A. CARLTON ERNSTENE, M.D.



Similar documents
The P Wave: Indicator of Atrial Enlargement

Aging Well - Part V. Hormone Modulation -- Growth Hormone and Testosterone

Emergency Scenario. Chest Pain

INFORMED CONSENT INFORMED CONSENT FOR PARTICIPATION IN A HEALTH AND FITNESS TRAINING PROGRAM

CIGI Direct Insurance Services, Inc. QUICK QUOTE CORONARY ANGIOPLASTY/CORONARY BYPASS

General SD Initial Visit Patient Questionnaire Men s Health Center LAST NAME: FIRST NAME: DOB:

CONGESTIVE HEART FAILURE PATIENT TEACHING

Congestive Heart Failure

Equine Cardiovascular Disease

Exchange solutes and water with cells of the body

Tired, Aching Legs? Swollen Ankles? Varicose Veins?

Biology 347 General Physiology Lab Advanced Cardiac Functions ECG Leads and Einthoven s Triangle

AXIRON (AXE-e-RON) CIII

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES

Cardioversion for. Atrial Fibrillation. Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation

Chemotherapy Side Effects Worksheet

Anatomi & Fysiologi The cardiovascular system (chapter 20) The circulation system transports; What the heart can do;

SYMPTOMS Heart failure symptoms may vary and can be hard to detect. Symptoms may include:

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

How to read the ECG in athletes: distinguishing normal form abnormal

High Blood Pressure (Essential Hypertension)

Radiotherapy to the chest wall

CARDIOMYOPATHY SUPPORT GROUP IRELAND

Do You Know the Health Risks of Being Overweight?

Thyroid Eye Disease. Anatomy: There are 6 muscles that move your eye.

How To Understand What You Know

Medication Guide Testim (TĔS tim) CIII (testosterone gel)

Hypothyroidism clinical features and treatment. 1. The causes of hypothyroidism

What are spider veins? What is the best treatment for spider veins?

12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P

Low Blood Pressure. This reference summary explains low blood pressure and how it can be prevented and controlled.

Liver Function Essay

Linfoma maligno pulmonar tratado com Nerium oleander. CASE REPORT

Application For Admission To The Non-Surgical Spinal Decompression Program At The Spinal Decompression Center of Long Beach

CorCap Cardiac Support Device Patient Information Booklet

X-Plain Diabetes - Introduction Reference Summary

Full name DOB Age Address Phone numbers (H) (W) (C) Emergency contact Phone

TERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES. Definitions for Common Terms Related to Type 2 Diabetes

New 7/1/2015 MCFRS 1

The Radiotherapy Department Radiotherapy to the chest wall and lymph nodes

The Family Library. Understanding Diabetes

Cardiac Rehabilitation

Preoperative Laboratory and Diagnostic Studies

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

Congestive Heart Failure

Understanding the Electrocardiogram. David C. Kasarda M.D. FAAEM St. Luke s Hospital, Bethlehem

HYPERTROPHIC CARDIOMYOPATHY

MEASURING AND RECORDING BLOOD PRESSURE

High Blood Sugar. Printable Materials

Effects of Moderate Altitude on patients with Pulmonary and Cardiac Impairment

What Can I Do about Atrial Fibrillation (AF)?

How To Treat Heart Valve Disease

Acquired Heart Disease: Prevention and Treatment

The insurance company checked above (Company) is responsible for the obligation and payment of benefits under any policy that it may issue.

Medication Guide ANDROGEL (AN DROW JEL) CIII (testosterone gel) 1%

GENERAL HEART DISEASE KNOW THE FACTS

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION

HEALTH RISK ASSESSMENT (HRS) QUESTIONNAIRE

MEDICATION GUIDE testosterone gel Testosterone (tes-tos-te-rone gel) CIII

Medical examination form

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.

The Radiotherapy Department Radiotherapy to the breast Information for patients

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.

JAMES PETROS, M.D., INC. PHONE: (408) FAX: (408)

Electronic Health Records Intake Form

Teriflunomide (Aubagio) 14mg once daily tablet

MEDICATION GUIDE Testosterone (tes-tos-te-rōn) Gel, CIII

Thyroid Disorders. Hypothyroidism

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

New Patient Evaluation

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

New England Pain Management Consultants At New England Baptist Hospital

Heart Diseases and their Complications

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Diabetes Mellitus Type 2

Presenting the SUTENT Patient Call Center.

VARICOSE VEINS. Information Leaflet. Your Health. Our Priority. VTE Ambulatory Clinic Stepping Hill Hospital

TCH: Docetaxel, Carboplatin and Trastuzumab

LOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH:

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

Atrial Fibrillation (AF) March, 2013

CardiacAdvantage. Catheterization. Patient Guide. Cardiac

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

MY TYPE 2 DIABETES NUMBERS

Type 2 diabetes Definition

HISTORY. Questions: 1. What diagnosis is suggested by this history? 2. How do you explain her symptoms during pregnancy?

Neuroendocrine Evaluation

Asbestos Related Diseases

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Hypothyroidism. What are the symptoms of Hypothyroidism?

Medical Direction and Practices Board WHITE PAPER

Cardiovascular diseases. pathology

Potential Causes of Sudden Cardiac Arrest in Children

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Blood vessels. transport blood throughout the body

Spotlight Series: Interventional Radiology. Varicose Veins and Venous Insufficiency

NEW STUDENT-ATHLETE MEDICAL HISTORY FORM

Transcription:

MYXEDEMA HEART WILBUR E. FLANNERY, M.D. and A. CARLTON ERNSTENE, M.D. The term "myxedema heart" was first employed by Zondek in 98 to describe a syndrome due to myxedema and nsisting of enlargement of the heart, sluggish cardiac movements, electrocardiographic changes, and ngestive myocardial failure. Although Zondek's observations have been fully nfirmed, it has been well established also that myxedema only rarely is mplicated by ngestive heart failure. Enlargement of the heart and changes in the electrocardiogram occur mmonly, however, and the term myxedema heart has now me to be applied to these changes even though evidence of ngestive failure is absent. Organic heart disease may also be present, and because of this, the cardiac abnormalities in any case of myxedema must be shown to be amenable to therapy with thyroid substance before one can nclude that they were due to myxedema heart. The present report is based on eight cases of myxedema in which electrocardiograms were made at the time the ndition was first diagnosed (table ). In two of the cases the symptoms had developed three months and nine years, respectively, after thyroidectomy, while in the other six, the ndition was of spontaneous origin. The age of the patients ranged from 37 years to 68 years. Five were women and three were men. The initial basal metabolic rates ranged between 24 per cent and 4 per cent, and the plasma cholesterol ncentrations between 96 mgm. per 00 cc. and 248 mgm. per 00 cc. The resting pulse rate ranged from 48 to 78 beats per minute, the systolic blood pressure from 08 to 60 mm. of mercury, and the diastolic pressure from 70 to 00 mm. of mercury. Roentgenograms of the chest were made in five cases before the institution of, but in only two of these were additional films made at a later date. In four of the five cases the transverse diameter of the heart shadow exceeded one-half the internal diameter of the chest by 0.6 cm. to.5 cm. In the other case, cardiac enlargement appears to have been present also for the transverse diameter of the heart shadow after four months of with thyroid substance was.8 cm. less than in the original films. Electrocardiographic abnormalities were rerded in all eight cases (table ). The P-waves were iso-electric or of subnormal amplitude in all. The QRS mplexes were of low voltage in four, while in a fifth, although the voltage was within normal limits at the of, thyroid therapy resulted in an increase in amplitude. In all eight cases, the T-waves were of low amplitude, iso-electric, or inverted in all three nventional leads. T-IVF was inverted in three of the five cases in which prerdial leads were rerded. Auriculoventricular nduc- 29

\ ' WILBUR E. FLANNERY AM) A. CARLTON ERIN STEN E Blood Pressure Systolic Diastolic mm. Hg. mm. Hg. Infernal Transverse D ia meter D ia meter of Thorax \ of Heart cm. ' cm. Electrocardiogram 50 : 98 P-waves isoelectric. Low voltage of QHS. T-I! 30.0 j 6.5 and II inverted. Low T-III. T-IV F inverted. P-I iso-electric. P-II and III normal. QRS m- 30.0 [ 4.0 plexes of greater amplitude. T-I, II, and IV F ; upright. Low T-III.! i CC P-I, II, and III upright. QRS mplexes of 30.4 6.5 greater amphtude. T-I, II, III, and IV F of ' greater amplitude. te Ov O s o 28.0 j 5.2 Low P-waves. Low voltage of QRS. T-I, II, III, and IV F inverted. Left axis deviation. i P-waves and QRS mplexes of greater voltage. 29.2 5.2, T-I, II, and IV F upright. T-III inverted. Left i : axis deviation. i 06 on Low P-waves. P-R = 0.24 send. QRS mplexes of normal amplitude. T-I, II, and IV F I inverted. T-III diphasic. Left axis deviation. ) Low P-waves. QRS mplexes of normal ampli- 29.2 5.2! 30 98 tude. Low T-I. T-II, III inverted. T-IV F ;! normal. 06! 0T Low P-waves. QRS mplexes of normal ampli- j tude. Low T-I. T-II iso-electric. T-III inverted. T-IV F normal. 38 00 3.8 4.5 Low P-waves. QRS mplexes of normal ampli- tude. Low T-I. T-II and III inverted. i Normal P-waves. QRS mplexes of greater 3.8 j 2.7 voltage. T-I normal. T-II upright but low. : T-III inverted.... ci sc «X, Low P-waves. QRS mplexes of low voltage. Low T-I. Flat T-II. Inverted T-III. P-waves and QRS mplexes of normal amplitude. T-I and II normal. T-III inverted. P-waves and QRS mplexes of low voltage. T-I inverted. Low T-I and II. j Pulse Rate i <N V k > <N C) t- t- tí" o so c V t- so Basal Plasma Sex Metabolic Cholesterol Rate mgm/ioocc., Per Cent { <M so Í F j IM < «i.o 4 weeks after 6 months after i - 24 i Lb One month after ± 0!! - 38 rf- - 28 LIZ so C\. o 4 months after fri 7 * 4 months after Lb Lb s s ta s TP Age ; Years s O 00 r- m r- rf Case No. j - <M U0 so t-* 30

MYXEDEMA HEART tion was prolonged in one case but it is not certain that this change was due to myxedema, since no subsequent tracings were made after the patient had been receiving thyroid substance. In four cases additional electrocardiograms were made after the patient had been receiving thyroid substance for one to five months, and in all, the original abnormalities were found to have been rrected. None of the eight patients presented signs of ngestive heart failure, but five had experienced dyspnea on slight or moderate exertion. The following case report illustrates the most important features of myxedema heart not acmpanied by ngestive heart failure. CASE REPORT Case I: A white married woman, 56 years of age, had experienced an attack of influenza two years before and shortly afterward noted swelling of the soft tissues of the head and face and puffiness under the eyes. The swelling varied in degree from day to day and was usually worse in the mornings. After one year, swelling, burning pain, and paresthesia had developed in the hands, and to a lesser degree in the feet. The sensory disturbances were aggravated by exposure to ld. The hair had beme drier and the skin dry and rough. The weight had increased, but the actual amount gained was not known. Weakness, fatiguability, and apathy were prominent symptoms, and there was mild dyspnea on limited exertion. Physical examination: The patient was 6% inches tall and weighed 74 pounds. The face was full and the expression dull. There was distinct puffiness about the eyes. The hair was thin and dry and the skin dry and of a lemon-yellow tint. The tongue was full and thick. There was no palpable thyroid tissue. The lungs were clear on percussion and auscultation. The area of relative cardiac dullness extended cm. to the left of the midsternal line in the fifth interstal space. The heart rhythm was regular and the rate 52 beats per minute. A faint systolic murmur was present over the aortic area. All heart sounds were of average quality. The peripheral arteries were not appreciably thickened, and the arterial pressure was 50 mm. systolic and 98 mm. diastolic. The liver was not enlarged or tender. The hands, forearms, feet, and lower legs appeared swollen but there was no pitting edema. Examination of the urine gave normal findings. The red blood cell unt was 4,30,000 per cu. mm., and the hemoglobin ntent 7 per cent. The white blood cell unt was 6,50 per cu. mm. The plasma cholesterol ntent was 263 mgm. per 00 cc., and the Wassermann and Kahn reactions of the blood were negative. The basal metabolic rate was 36 per cent. A teleroentgenogram showed the transverse diameter of the heart shadow to be 6.5 cm. and 3

WILBUR E. FLANNERY AM) A. CARLTON ERNSTENE

MYXEDEMA HEART the internal diameter of the thorax 30 cm. An electrocardiogram (figure ) showed sinus rhythm with a rate of 58 per minute. The QRS mplexes were of low voltage and the P-waves were iso-electric in all leads. The T-waves were inverted in leads I, II, and IV F and of low amplitude in lead III. Armour's desiccated thyroid was prescribed in doses of three grains daily for two weeks, and the dosage was then reduced to two grains daily. Twenty-seven days after, the patient's weight had decreased to 5 pounds and there was striking improvement in her general appearance. The basal metabolic rate was 4 per cent and the plasma cholesterol ntent 28 mgm. per 00 cc. The electrocardiogram (figure ) was normal except for an iso-electric P-I and a flat T-III. The heart rate was 60 beats per minute. The patient was advised to ntinue to take two grains of desiccated thyroid daily for one more month, and then to reduce the dose to one grain daily. Six months after the institution of therapy, the patient's general appearance was quite normal and she mplained only of occasional tingling in the hands. The weight was 29 pounds, the pulse rate 60 beats per minute, and the blood pressure 32 mm. systolic and 84 mm. diastolic. The basal metabolic rate was 5 per cent and the plasma cholesterol ntent 83 mgm. per 00 cc. A teleroentgenogram showed the transverse diameter of the heart shadow to be 2.5 cm. smaller than at the time of the first examination. The electrocardiogram was within normal limits except for a low P-I (figure ). The red blood cell unt was 4,470,000 per cu. mm. and the hemoglobin ntent 84 per cent. The patient was advised to ntinue to take one grain of desiccated thyroid daily. DISCUSSION Knowledge of the pathology of myxedema heart is based on the examination of only a small amount of material 2. The significant changes nsist of interstitial edema and more or less myocardial fibrosis. Coronary artery sclerosis is often present. The increase in the size of the cardiac shadow in teleroentgenograms has been variously explained in the past as the result principally of hypertrophy of the heart, dilatation of the heart, or pericardial effusion. The prompt and often nsiderable diminution in the size of the shadow after the institution of with thyroid substance is strong evidence against the presence of any great degree of true hypertrophy. Pericardial effusion is present at times, but in most cases of myxedema neither the clinical findings nor the roentgenographic appearance are nsistent with the presence of significant amounts of fluid in the pericardium' 5. There is general agreement at present that the cardiac enlargement in myxedema is due chiefly to dilatation, but interstitial edema may be a minor ntributory factor. 33

WILBUR E. FLANNERY AM) A. CARLTON ERIN STEN E Changes in the electrocardiogram occur even more mmonly in myxedema than does enlargement of the heart. Although many types of abnormalities have been rerded, the only one that is characteristic nsists of iso-electric or inverted P- and T-waves in all leads. The QRS mplexes, however, are often of subnormal amplitude. Neither the electrocardiographic abnormalities nor the cardiac enlargement of myxedema are rrected by the use of digitalis. Thyroid substance in adequate amounts, on the other hand, brings about a mplete return of all changes to normal. Overdosage must be carefully avoided, and whenever the heart is nsiderably enlarged or there is a history of angina pectoris, only small amounts of thyroid should be given. The effect of on the basal metabolic rate, heart size, and electrocardiogram should be checked periodically, and as soon as the maximum degree of improvement has been attained, the daily dose of thyroid should be reduced to the lowest level that will maintain this state. SUMMARY The roentgenographic and electrocardiographic findings in eight cases of myxedema heart have been summarized, and one case has been reported in detail. REFERENCES. Zondek, II.: Das Myxodeinherz, Miinchen med. Wchnschr., 65:80-82, 98. 2. Higgins, W. H.: The heart in myxedema: rrelation of physical and postmortem findings, Am. J. Med. Sc., 9:80-88, (January) 936. 3. Lerman, J., Clark, R. J. and Means, J. H.: Heart in myxedema; electrocardiographic and roentgen-ray measurements before and after therapy, Ann. Int. Med., 6:25-27, (April) 933. 34